Growing Potential of India's Medical disposables Industry: Policy Boost Required

Growing Potential of India's Medical disposables Industry: Policy Boost Required

Rajiv Nath, MD, Hindustan Syringes & Medical Device Ltd. & Forum Coordinator - AIMED

 medical disposables, IoT, AI, Make in India, personal protective equipment (PPE), energy-efficient manufacturing

In an exclusive interview with Thiruamuthan, Correspondent, India Pharma Outlook, Rajiv answered several queries on the growing potential of the medical disposables industry and why it requires a policy boost now. Rajiv Nath is a business expert with over three decades of expertise in the medical field. He is also the President of the All India Syringes & Needles Manufacturers Association (AISNMA) and the Founder and Forum Coordinator at the Association of Indian Medical Device Industry (AIMED).

Could you elaborate on the current trends and significant developments shaping the medical disposables industry, especially concerning sustainability initiatives?

The medical disposables industry is undergoing significant transformation, with environmental sustainability emerging as a key trend shaping its future both in India and globally. There is a growing emphasis on reducing the environmental impact of disposable medical products through the development of eco-friendly materials and innovative waste management practices as well as reduced material usage by review of design.

Biodegradable and compostable alternatives to traditional plastics are being increasingly explored, along with the use of renewable resources and sustainable manufacturing processes. Companies are investing in research and development to create products that maintain high standards of safety and efficacy while minimizing ecological carbon footprints.

Initiatives such as extended producer responsibility (EPR) are being adopted to ensure manufacturers take accountability for the entire lifecycle of their products. These trends are not only reshaping the industry but also aligning it with broader global sustainability goals.

How have recent technological advancements, including smart technologies and other innovations, influenced the production and quality of medical disposable products?

It goes without saying that technological advancements have significantly influenced the production and quality of medical disposable products, enhancing their efficiency and safety. The integration of smart technologies, such as IoT (Internet of Things) and AI (Artificial Intelligence) are now beginning to revolutionize manufacturing processes, enabling real-time monitoring and process controls to ensure precision and consistency in product quality.

Similarly, automated production lines equipped with robotics and advanced sensors and on line vision inspection systems to improve production throughput and reduce human error, while AI-driven analytics help in predictive maintenance and optimization of resources. Smart packaging solutions, incorporating features like RFID tags and QR codes, provide enhanced traceability and authentication, ensuring the integrity of medical disposables throughout the supply chain. Remote monitoring and Remote maintenance of equipment over internet are getting more common.

Moreover, advancements in sterilization technologies, such as low-temperature plasma and electron beam irradiation, ensure higher levels of sterility without compromising the structural integrity of the products. These technological innovations are driving the medical disposables industry towards higher standards of quality, safety, and efficiency.

In what ways have government policies, such as stringent safety standards and initiatives promoting environmental sustainability, influenced innovation and growth in the medical disposables sector?

Government policies have a significant influence on innovation and growth in the medical disposables sector. Regulations mandating high safety and quality standards ensure that medical disposable products meet international benchmarks, leading to trust and reliability in both domestic and global markets. All Medical Disposables are now under mandatory regulations under Medical Device Rules of 2017 under the Drugs and Cosmetics Act.

Government initiatives, such as the Make in India campaign, encourage local manufacturing and innovation, providing incentives and support for research and development in the medical disposables industry. The government’s emphasis on healthcare infrastructure development and its efforts to increase healthcare accessibility have also expanded the market for medical disposables, stimulating industry growth.

Could you highlight how the increasing emphasis on infection control and hygiene has impacted the demand for medical disposables?

The increasing emphasis on infection control and hygiene has significantly impacted the demand for medical disposables, driving substantial growth in this sector. There is a growing awareness about preventing hospital-acquired infections (HAIs) and cross-contamination as well, forcing healthcare facilities to adopt more stringent hygiene best practices along with single use disposables.

This shift has resulted in a higher demand for disposable products such as gloves, masks, gowns, syringes, and catheters, which are designed for single use to ensure sterility. The Covid-19 pandemic further underscored the critical need for infection control, massively boosting the consumption of personal protective equipment (PPE) and other disposable medical items.

Regulatory bodies have imposed stricter guidelines on infection prevention, compelling healthcare providers to increase their usage of disposable products. This trend extends beyond hospitals to clinics, diagnostic centres, and even home healthcare, reflecting a broader societal commitment to hygiene and patient safety.

When considering sustainability and minimizing environmental impact in the production of medical disposables, what challenges do manufacturers face in balancing cost-effectiveness with sustainability goals, and how is the industry addressing these challenges?

Manufacturers of medical disposables face significant challenges in balancing cost-effectiveness with sustainability goals, primarily due to the higher costs associated with eco-friendly materials and sustainable production processes. Traditional plastics are often cheaper and more readily available compared to biodegradable or compostable alternatives.

At the same time, implementing sustainable practices such as energy-efficient manufacturing, waste reduction, and recycling requires substantial investment in new technologies and infrastructure. To address these challenges, the industry is increasingly investing in research and development to create cost-effective sustainable materials and processes.

Some companies are adopting a circular economy approach, focusing on product lifecycle management, including the recycling and reusability of materials. Government incentives and subsidies for green manufacturing are also helping to offset the initial costs associated with sustainability initiatives. As consumer and regulatory pressures for sustainable products grow, the industry is gradually shifting towards more sustainable practices, finding innovative ways to reduce costs while minimizing environmental impact.

Looking forward, what are your perspectives on the future advancements and innovations expected to further enhance the medical disposables industry?

I am optimistic about future advancements and innovations in the medical disposables industry. I personally anticipate significant strides in material science, particularly the development of new biocompatible and biodegradable materials that ensure both safety and environmental sustainability. As I stated earlier, the integration of advanced technologies such as AI and IoT will revolutionize manufacturing processes, enabling real-time quality control, predictive maintenance, and efficient supply chain management.

We at AiMeD also foresee the rise of smart medical disposables equipped with sensors and connectivity features to monitor patient health and improve clinical outcomes as well as deployment of RFIT Tags for inventory movement monitoring and management.  A robust regulatory framework independent of Drugs that supports innovation while maintaining stringent safety and quality standards will position India as a global leader in the medical disposables sector.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.